827 results on '"Viapiana, Ombretta"'
Search Results
2. Long-Term Bone Mineral Density Changes in Kidney Transplant Recipients Treated with Denosumab: A Retrospective Study with Nonequivalent Control Group
3. Effects of tofacitinib on bone turnover markers and bone modulators in patients with rheumatoid arthritis
4. Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry
5. Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry
6. Unfolding dermatologic spectrum of Behçet’s disease in Italy: real-life data from the International AIDA Network Behçet’s disease Registry
7. Ultrasonographic non-radiographic erosions could predict the efficacy of belimumab in articular systemic lupus erythematosus
8. Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry
9. Changes in bone turnover markers and bone modulators during abatacept treatment
10. Risk of fracture in women with glucocorticoid requiring diseases is independent from glucocorticoid use: An analysis on a nation-wide database
11. Radiofrequency echographic multi-spectrometry and DXA for the evaluation of bone mineral density in a peritoneal dialysis setting
12. Clinical image: ultrasound findings and magnetic resonance imaging comparison in the muscular involvement in polyarteritis nodosa
13. The administration of methotrexate in patients with Still's disease, “real-life” findings from AIDA Network Still Disease Registry
14. Discontinuation of Infliximab leading to auditory loss in a patient with Cogan syndrome: a case report
15. Rheumatoid arthritis and myasthenia gravis: a case-based review of the therapeutic options
16. C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis
17. Stepping Forward to the Next Level: Totality of Evidence for the First High-Concentration Adalimumab Biosimilar, CT-P17
18. Real-world evidence of biologic treatments in psoriatic arthritis in Italy: results of the CHRONOS (EffeCtiveness of biologic treatments for psoriatic artHRitis in Italy: an ObservatioNal lOngitudinal Study of real-life clinical practice) observational longitudinal study
19. A real-world economic analysis of biologic therapies for psoriatic arthritis in Italy: results of the CHRONOS observational longitudinal study
20. The CHRONOS Real-World Evidence of Biologic Treatments in Psoriatic Arthritis in Italy: A Post Hoc Gender Analysis
21. A Review of Current Approaches to Pain Management in Knee Osteoarthritis with a Focus on Italian Clinical Landscape.
22. Effects of tofacitinib on bone turnover markers and bone modulators in patients with rheumatoid arthritis
23. Romosozumab added to ongoing denosumab in postmenopausal osteoporosis, a prospective observational study
24. Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group
25. Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome
26. Diffuse Idiopathic Skeletal Hyperostosis (DISH) in Type 2 Diabetes: A New Imaging Possibility and a New Biomarker
27. Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunction
28. Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry
29. Machine learning to characterize bone biomarkers profile in rheumatoid arthritis
30. Effects of cytotoxic T-lymphocyte-associated protein 4 compared to TNF inhibitors on lipid profile: Results from an observational multicentre rheumatoid arthritis cohort
31. Risk of fracture in women with glucocorticoid requiring diseases is independent from glucocorticoid use: An analysis on a nation-wide database
32. The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases
33. Factors associated with referral for osteoporosis care in men: a real-life study of a nationwide dataset
34. Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritis
35. Traditional cardiovascular risk factors and residual disease activity are associated with atherosclerosis progression in rheumatoid arthritis patients
36. Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study
37. Real‐world effectiveness and persistence of golimumab as second‐line anti‐TNFα drug in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis patients in Italy: GO‐BEYOND, a 12‐month prospective observational study
38. Long-term effectiveness and predictors of bisphosphonate treatment in type I complex regional pain syndrome
39. Bone Disease in Mastocytosis
40. The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions
41. Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis
42. Predictors and prognostic role of low myocardial mechano-energetic efficiency in chronic inflammatory arthritis
43. Effects of cytotoxic T-lymphocyte-associated protein 4 compared to TNF inhibitors on lipid profile: Results from an observational multicentre rheumatoid arthritis cohort
44. A patient-driven registry on Behçet’s disease: the AIDA for patients pilot project
45. C-reactive protein level association with future cardiovascular events assessed by different risk scores among rheumatoid arthritis patients
46. Bone loss occurs in Inflammatory Rheumatic Musculoskeletal Diseases ( iRMD ) patients treated with low dose glucocorticoids, but is prevented by anti‐osteoporosis medications
47. Bone Loss in Inflammatory Rheumatic Musculoskeletal Disease Patients Treated With Low‐Dose Glucocorticoids and Prevention by Anti‐Osteoporosis Medications.
48. Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study
49. Clinical Features of Diabetes Mellitus on Rheumatoid Arthritis: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group
50. Factors associated with radiographic progression in rheumatoid arthritis starting biological diseases modifying anti-rheumatic drugs (bDMARDs)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.